Psychiatry · Seattle, WA
NPI
1437258415
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1221 Madison St, Swedish Cancer Institute - Suite 400
Seattle, WA, 98104
Phone (206) 320-4910
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$216K
340 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Dorcas J Dobie prescribed most often to Medicare patients was Mirtazapine, with 37 prescriptions and refills. In total Dorcas J Dobie wrote 340 Medicare prescriptions that cost $216K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Mirtazapine Generic | 37 | 79 | Under 11 | $336 |
| Gabapentin Generic | 37 | 54 | Under 11 | $457 |
| Methylphenidate Er Methylphenidate Hcl | 24 | 24 | Under 11 | $2,392 |
| Trazodone Hcl Generic | 23 | 31 | Under 11 | $208 |
| Lamotrigine Generic | 21 | 48 | Under 11 | $460 |
| Clonazepam Generic | 19 | 19 | Under 11 | $74.47 |
| Duloxetine Hcl Generic | 19 | 37 | Under 11 | $537 |
| Emsam Selegiline | 14 | 14 | Under 11 | $27K |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 14 | 24 | Under 11 | $167 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 13 | 39 | Under 11 | $238 |
| Wellbutrin Xl Bupropion Hcl | 13 | 37 | Under 11 | $175K |
| Fluvoxamine Maleate Generic | 12 | 36 | Under 11 | $482 |
| Bupropion Xl Bupropion Hcl | 11 | 21 | Under 11 | $226 |
| Divalproex Sodium Er Divalproex Sodium | 11 | 11 | Under 11 | $725 |
Brand drugs: 35 claims; generic drugs: 305 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Dorcas J Dobie were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.